Therefore, we focused on the role of necroptosis in diabetic nephropathy (DN) and identified EGF, PAG1, and ZFP36 as potential biomarkers associated with necroptosis using the WGCNA algorithm. This evidence concerns the gene EGF and liver dysplastic nodule.